Cargando…

Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS)

COPD has a profound impact on daily life, yet remains underdiagnosed and undertreated. We set out to develop a brief, reliable, self-scored questionnaire to identify individuals likely to have COPD. COPD-PS™ development began with a list of concepts identified for inclusion using expert opinion from...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Fernando J., Raczek, Anastasia E., Seifer, Frederic D., Conoscenti, Craig S., Curtice, Tammy G., D'Eletto, Thomas, Cote, Claudia, Hawkins, Clare, Phillips, Amy L.
Formato: Texto
Lenguaje:English
Publicado: Informa Healthcare 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430173/
https://www.ncbi.nlm.nih.gov/pubmed/18415807
http://dx.doi.org/10.1080/15412550801940721
_version_ 1782156361093611520
author Martinez, Fernando J.
Raczek, Anastasia E.
Seifer, Frederic D.
Conoscenti, Craig S.
Curtice, Tammy G.
D'Eletto, Thomas
Cote, Claudia
Hawkins, Clare
Phillips, Amy L.
author_facet Martinez, Fernando J.
Raczek, Anastasia E.
Seifer, Frederic D.
Conoscenti, Craig S.
Curtice, Tammy G.
D'Eletto, Thomas
Cote, Claudia
Hawkins, Clare
Phillips, Amy L.
author_sort Martinez, Fernando J.
collection PubMed
description COPD has a profound impact on daily life, yet remains underdiagnosed and undertreated. We set out to develop a brief, reliable, self-scored questionnaire to identify individuals likely to have COPD. COPD-PS™ development began with a list of concepts identified for inclusion using expert opinion from a clinician working group comprised of pulmonologists (n = 5) and primary care clinicians (n = 5). A national survey of 697 patients was conducted at 12 practitioner sites. Logistic regression identified items discriminating between patients with and without fixed airflow obstruction (AO, postbronchodilator FEV(1)/FVC < 70%). ROC analyses evaluated screening accuracy, compared scoring options, and assessed concurrent validity. Convergent and discriminant validity were assessed via COPD-PS and SF-12v2 score correlations. For known-groups validation, COPD-PS differences between clinical groups were tested. Test-retest reliability was evaluated in a 20% sample. Of 697 patients surveyed, 295 patients met expert review criteria for spirometry performance; 38% of these (n = 113) had results indicating AO. Five items positively predicted AO (p < 0.0001): breathlessness, productive cough, activity limitation, smoking history, and age. COPD-PS scores accurately classified AO status (area under ROC curve = 0.81) and reliable (r = 0.91). Patients with spirometry indicative of AO scored significantly higher (6.8, SD = 1.9; p < 0.0001) than patients without AO (4.0, SD = 2.3). Higher scores were associated with more severe AO, bronchodilator use, and overnight hospitalization for breathing problems. With the prevalence of COPD in the studied cohort, a score on the COPD-PS of greater than five was associated with a positive predictive value of 56.8% and negative predictive value of 86.4%. The COPD-PS accurately classified physician-reported COPD (AUC = 0.89). The COPD-PS is a brief, accurate questionnaire that can identify individuals likely to have COPD.
format Text
id pubmed-2430173
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Informa Healthcare
record_format MEDLINE/PubMed
spelling pubmed-24301732008-06-27 Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS) Martinez, Fernando J. Raczek, Anastasia E. Seifer, Frederic D. Conoscenti, Craig S. Curtice, Tammy G. D'Eletto, Thomas Cote, Claudia Hawkins, Clare Phillips, Amy L. COPD Original Research COPD has a profound impact on daily life, yet remains underdiagnosed and undertreated. We set out to develop a brief, reliable, self-scored questionnaire to identify individuals likely to have COPD. COPD-PS™ development began with a list of concepts identified for inclusion using expert opinion from a clinician working group comprised of pulmonologists (n = 5) and primary care clinicians (n = 5). A national survey of 697 patients was conducted at 12 practitioner sites. Logistic regression identified items discriminating between patients with and without fixed airflow obstruction (AO, postbronchodilator FEV(1)/FVC < 70%). ROC analyses evaluated screening accuracy, compared scoring options, and assessed concurrent validity. Convergent and discriminant validity were assessed via COPD-PS and SF-12v2 score correlations. For known-groups validation, COPD-PS differences between clinical groups were tested. Test-retest reliability was evaluated in a 20% sample. Of 697 patients surveyed, 295 patients met expert review criteria for spirometry performance; 38% of these (n = 113) had results indicating AO. Five items positively predicted AO (p < 0.0001): breathlessness, productive cough, activity limitation, smoking history, and age. COPD-PS scores accurately classified AO status (area under ROC curve = 0.81) and reliable (r = 0.91). Patients with spirometry indicative of AO scored significantly higher (6.8, SD = 1.9; p < 0.0001) than patients without AO (4.0, SD = 2.3). Higher scores were associated with more severe AO, bronchodilator use, and overnight hospitalization for breathing problems. With the prevalence of COPD in the studied cohort, a score on the COPD-PS of greater than five was associated with a positive predictive value of 56.8% and negative predictive value of 86.4%. The COPD-PS accurately classified physician-reported COPD (AUC = 0.89). The COPD-PS is a brief, accurate questionnaire that can identify individuals likely to have COPD. Informa Healthcare 2008-04-15 2008-04 /pmc/articles/PMC2430173/ /pubmed/18415807 http://dx.doi.org/10.1080/15412550801940721 Text en © Informa Healthcare USA, Inc. http://creativecommons.org/licenses/by/2.0/ This is an open access article distributed under the Supplemental Terms and Conditions for iOpenAccess articles published in Informa Healthcare journals (http://www.informaworld.com/mpp/uploads/iopenaccess_tcs.pdf) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Martinez, Fernando J.
Raczek, Anastasia E.
Seifer, Frederic D.
Conoscenti, Craig S.
Curtice, Tammy G.
D'Eletto, Thomas
Cote, Claudia
Hawkins, Clare
Phillips, Amy L.
Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS)
title Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS)
title_full Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS)
title_fullStr Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS)
title_full_unstemmed Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS)
title_short Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS)
title_sort development and initial validation of a self-scored copd population screener questionnaire (copd-ps)
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430173/
https://www.ncbi.nlm.nih.gov/pubmed/18415807
http://dx.doi.org/10.1080/15412550801940721
work_keys_str_mv AT martinezfernandoj developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps
AT raczekanastasiae developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps
AT seiferfredericd developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps
AT conoscenticraigs developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps
AT curticetammyg developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps
AT delettothomas developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps
AT coteclaudia developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps
AT hawkinsclare developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps
AT phillipsamyl developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps